Agoracom Blog Home

Posts Tagged ‘covid19’

Loop Insights $MTRX $RACMF Enters UK Market With Pilot Agreement For Leading UK Pharmacy Solutions Provider, Servicing 12,000 Pharmacies Across United Kingdom $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 7:37 AM on Thursday, January 14th, 2021
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png
  • Announced the signing of a Pilot Agreement with PharmAssist Solutions to implement Loop’s analytics platform into multiple independent pharmacy affiliated locations.
  • Pharmassist is an independent pharmacy solutions provider that serves 15% of the UK market with 12,000 independent pharmacies.
  • Upon successful completion of the Pilot, it is the intention of both parties to implement Loop’s artificial intelligence-driven analytics platform across all 12,000 pharmacies in the United Kingdom.

VANCOUVER, British Columbia, Jan. 14, 2021 — Loop Insights Inc. (MTRX:TSXV)(RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated contact tracing to the brick and mortar space, is pleased to announce the signing of a Pilot Agreement with PharmAssist Solutions (“ Pharmassist ”) to implement Loop’s analytics platform into multiple independent pharmacy affiliated locations.

OPPORTUNITY FOR FULL IMPLEMENTATION ACROSS 12,000 LOCATIONS

Pharmassist is an independent pharmacy solutions provider that serves 15% of the UK market with 12,000 independent pharmacies. Upon successful completion of the Pilot, it is the intention of both parties to implement Loop’s artificial intelligence-driven analytics platform across all 12,000 pharmacies in the United Kingdom.

Pharmassist Managing Director Amar Randhawa stated, “Loop Insights data analytics solution is a game-changer for independent pharmacies here in the UK. PharmAssist Solutions has been integral to the success of the independent chain, and adding Loop’s ability to understand transaction details, shopping behaviors and habits, trends, and other powerful pieces of information once thought lost, will provide a massive benefit to each individual pharmacy. Understanding what products have been sold and prescribed gives these independents the ability to offer personal, relevant, and adjacent over the counter products to consumers, increasing sales, and delivering a more personal experience in-store. We are excited to be the first solutions provider in the UK market to offer this, and expect great uptake of the solution to our growing customer base.”

INSIGHTS REVENUE MODEL PROVIDES POTENTIAL FOR $USD 28.8 MILLION IN ANNUAL REVENUES UPON SUCCESSFUL COMPLETION OF PILOT

On November 4, 2020 , Loop announced it successfully completed a similar Pilot at 20 stores and was rolling out to all 550 retail locations of Your CBD Store . In that press release, the Company provided details with respect to its “Insights” pricing model including $USD 50 per month per till, with an average of 4 tills per retail location, which would equate to potential monthly recurring revenue of $USD 2,400,000 or $USD 28,800,000.

In addition, when the Company’s automated marketing “Engage” service and wallet pass loyalty applications are layered in, these numbers quickly multiply by 5-10x and provide the company with an even more significant potential revenue stream.

Loop Insights CEO Rob Anson stated, “Signing this Pilot with Pharmassist in the very early days of 2021 serves as a strong indication of Loop’s anticipated penetration into the UK and European markets. Coupled with our recently announced LOI to acquire Passcreator and take control of our technology in anticipation of major business developments in 2021, I can unequivocally say that Loop is heading into a major growth phase as promised in our letter to shareholders at the end of 2020.”

Read More: https://agoracom.com/ir/LoopInsights/forums/discussion/topics/752999-loop-insights-enters-uk-market-with-pilot-agreement-for-leading-uk-pharmacy-solutions-provider-servicing-12-000-pharmacies-across-united-kingdom/messages/2297830#message

Datametrex $DM.ca $DTMXF Announces Strategic Review of Ronin #Blockchain $HUT.ca $BITF.ca $GLXY.ca $HIVE.ca $VYGR.ca

Posted by AGORACOM-JC at 8:00 AM on Wednesday, January 13th, 2021
  • Announced that its wholly owned subsidiary, Ronin Blockchain Corp., a cryptocurrency mining platform, will be revisited by the Company with a view to evaluate various strategic options for the purpose of reactivating the cryptocurrency mining platform to maximize value for the shareholders of the Company.
  • Bitcoin has had a unpresidented run up in value in the last three months from below USD$10,000 to over USD$40,000.
  • This may also include without limitation, a share dividend or an alternative similar transaction.

Toronto, Ontario–(January 13, 2021) –  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that its wholly owned subsidiary, Ronin Blockchain Corp. (“Ronin”), a cryptocurrency mining platform, will be revisited by the Company with a view to evaluate various strategic options for the purpose of reactivating the cryptocurrency mining platform to maximize value for the shareholders of the Company. This may also include without limitation, a share dividend or an alternative similar transaction.

As part of this strategic review process, Datametrex board and management will collectively review all aspects Ronin to create a strategic plan for the business unit in light of the favourable market conditions which exist for bitcoin and cryptocurrency. Bitcoin has had a unpresidented run up in value in the last three months from below USD$10,000 to over USD$40,000.

According to Forbes[1], a leaked CitiFX report from US banking giant Citibank executive and senior analyst Tom Fitzpatrick has revealed bitcoin could potentially hit a high of $318,000 by December 2021, calling it “21st century gold.” The report was first leaked to the cryptocurrency community by Twitter user “ClassicMacro” in a tweet on November 16, 2020, noting Fitzpatrick is “a big fan of moon targets.”

“With strong run up on Bitcoin, it would prudent for the company and a benefit with our shareholders to complete a full review of Ronin,” said Marshall Gunter, CEO of Datametrex. “Many people within the cryptocurrency space have noted many institutional investors say crypto may be in the middle of a unthinkable rally.”

Read More: https://agoracom.com/ir/DatametrexAI/forums/discussion/topics/752909-datametrex-announces-strategic-review-of-ronin-blockchain/messages/2297543#message

Loop Insights $MTRX $RACMF Signs LOI To Acquire #Passcreator, A Leading European Digital Wallet And Mobile Marketing Company With Tier-1 Global Clients $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 7:16 AM on Tuesday, January 12th, 2021
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png
  • Announced the signing of a Letter Of Intent to acquire Passcreator, a leading European digital wallet and mobile marketing company with Tier-1 clients such as Mercedes-Benz and BMW.
  • Loop commenced its technology partnership with Passcreator early in 2020 to provide Loop with the support necessary to deliver on its anticipated first-stage developments in the sports venue, hospitality, travel, and health industries.
  • The acquisition is expected to be completed by late January or early February 2021, subject to customary due diligence and Exchange approvals.

VANCOUVER, British Columbia, Jan. 12, 2021 — Loop Insights Inc. (MTRX:TSXV) (RACMF:OTCQB) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement and automated venue tracing to the brick and mortar space, is pleased to announce the signing of a Letter Of Intent (“LOI”) to acquire Passcreator, a leading European digital wallet and mobile marketing company with Tier-1 clients such as Mercedes-Benz and BMW. The acquisition is expected to be completed by late January or early February 2021, subject to customary due diligence and Exchange approvals.

Acquisition of Passcreator to Provide Loop with Complete Control Over its Digital Wallet Pass Technology In Anticipation of Upcoming Business Developments

Loop commenced its technology partnership with Passcreator early in 2020 to provide Loop with the support necessary to deliver on its anticipated first-stage developments in the sports venue, hospitality, travel, and health industries. To this end, on December 29, 2020, Loop Insights announced its most successful year in Company history , including partnerships with major telecom companies TELUS and NTT DATA.

Read More: https://agoracom.com/ir/LoopInsights/forums/discussion/topics/752785-loop-insights-signs-loi-to-acquire-passcreator-a-leading-european-digital-wallet-and-mobile-marketing-company-with-tier-1-global-clients/messages/2297155#message

Datametrex $DM.ca $DTMXF Sold over 23,000 COVID-19 PCR Tests in Q4 $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 7:11 AM on Tuesday, January 12th, 2021
  • Announced that it sold over 23,000 onsite tests for the film industry at locations in Montreal, Toronto and Vancouver for the months of October through December 2020.
  • This represents approximately $4,000,000 CAD in top-line revenue for Q4. As stated on September 24th, 2020, the company secured contracts with one of the worlds largest film and television production companies to provide PCR test kits.
  • The total amount of the contracts if fully executed was over $20M CAD. Datametrex has increased its lab and testing capacity to facilitate demand and has positioned the Company to ramp up testing in 2021.

Toronto, Ontario–(January 12, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce that it sold over 23,000 onsite tests for the film industry at locations in Montreal, Toronto and Vancouver for the months of October through December 2020. This represents approximately $4,000,000 CAD in top-line revenue for Q4. As stated on September 24th, 2020, the company secured contracts with one of the worlds largest film and television production companies to provide PCR test kits. The total amount of the contracts if fully executed was over $20M CAD. Datametrex has increased its lab and testing capacity to facilitate demand and has positioned the Company to ramp up testing in 2021. The Company plans to continue increasing its capacity to expand its services to additional film and production companies as their demand increases daily.

Major Hollywood studios and streamers have kept shooting movies and TV series on film and TV sets in Montreal, Toronto, and Vancouver while weathering the most recent record COVID-19 infection rates in Canada.

Read More: https://agoracom.com/ir/DatametrexAI/forums/discussion/topics/752784-datametrex-sold-over-23-000-covid-19-pcr-tests-in-q4/messages/2297154#message

Datametrex $DM.ca $DTMXF Providing COVID-19 Testing for Air Canada $AC.ca Front-Line and Inflight Employees $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 8:01 AM on Monday, January 11th, 2021
  • Company has commenced providing COVID-19 testing for Air Canada’s front-line employees who interact with members of the travelling public.
  • The Company’s COVID testing arrangement with Air Canada is being done on an as-needed basis as Datametrex has been selected as one of the testing and travel partners of Air Canada as publicly disclosed by Air Canada in a tweet dated November 22, 2020.

Toronto, Ontario–(January 11, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to provide an update on its COVID-19 testing business and announce that the Company has commenced providing COVID-19 testing for Air Canada’s (“Air Canada”) front-line employees who interact with members of the travelling public. The Company’s COVID testing arrangement with Air Canada is being done on an as-needed basis as Datametrex has been selected as one of the testing and travel partners of Air Canada as publicly disclosed by Air Canada in a tweet dated November 22, 2020.

The PCR based COVID-19 testing to be arranged by the Company will be for Air Canada employees including, pilots, pilot trainees, and flight attendants.

“With many companies looking to keep employees safe and healthy and especially with flight crews requiring a negative COVID-19 test to fly, Datametrex is proud to be a solution partner with Air Canada to safely and with confidence keep its flight crews and customers alike protected. Datametrex has provided thousands of PCR based tests to companies and employees over the last seven months and believes that continued testing of the public is the gold standard to protecting everyone and containing the spread of the COVID-19 virus,” commented Marshall Gunter, Datametrex’s Chief Executive Officer.

Read More: https://agoracom.com/ir/DatametrexAI/forums/discussion/topics/752721-datametrex-providing-covid-19-testing-for-air-canada-front-line-and-inflight-employees/messages/2296944#message

Datametrex $DM.ca $DTMXF Congratulate Graph Blockchain $GBLC.ca

Posted by AGORACOM-JC at 2:53 PM on Friday, January 8th, 2021

Toronto, Ontario–(January 8, 2021) – Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) would like to congratulate its investee company, Graph Blockchain (GBLC: CSE) on the recent share price appreciation.

“Datametrex remains a significant shareholder of Graph Blockchain owning approximately 25% of Graph. We welcome any new direction the board and management determine to be in the best interest of GBLC and its shareholders,” says Marshall Gunter CEO of the Company.

Read More: https://agoracom.com/ir/DatametrexAI/forums/discussion/topics/752644-datametrex-congratulate-graph-blockchain/messages/2296719#message

Loop Insights $MTRX $RACMF Selected by bdG Sports to Provide Venue Management Platform to #NCAA Big West Conference Championships at Mandalay Bay in Las Vegas $AT.ca $QTRH.ca $SNSR $BSQR $PTS.ca

Posted by AGORACOM-JC at 7:35 AM on Friday, January 8th, 2021
https://miro.medium.com/max/3150/1*f9msDHyceA_TbRM30jQhsw.png

Company Continues its Track Record of Successful “Bubble” Implementations with bdG Sports

  • Company has been selected by bdG Sports to provide its venue management platform to the Big West Conference Men’s and Women’s Basketball Championships being held March 9-13, 2021 at the Mandalay Bay Events Center in Las Vegas.
  • A total of 19 men’s and women’s NCAA basketball teams will compete in the Big West Conference Finals for a chance to enter the NCAA 2020-2021 “March Madness” Tournament in Las Vegas.
  • Loop’s selection to provide its venue management platform at the Big West Conference Championships follows the successful deployment of Loop’s venue bubble solution at two previous NCAA basketball tournaments, the Gulf Coast Showcase and the Vegas Main Event.

VANCOUVER, British Columbia, Jan. 08, 2021 — Loop Insights Inc. (MTRX:TSXV OTCQB:RACMF) (the “Company” or “Loop”), a provider of contactless solutions and artificial intelligence (“AI”) to drive real-time insights, enhanced customer engagement, and automated venue tracing to the brick and mortar space, is pleased to announce the Company has been selected by bdG Sports to provide its venue management platform to the Big West Conference Men’s and Women’s Basketball Championships being held March 9-13, 2021 at the Mandalay Bay Events Center in Las Vegas.

A total of 19 men’s and women’s NCAA basketball teams will compete in the Big West Conference Finals for a chance to enter the NCAA 2020-2021 “March Madness” Tournament in Las Vegas. Loop’s selection to provide its venue management platform at the Big West Conference Championships follows the successful deployment of Loop’s venue bubble solution at two previous NCAA basketball tournaments, the Gulf Coast Showcase and the Vegas Main Event.

With fans expected to be live in attendance, the company’s Wallet pass technology will provide revenue share opportunities through its previous affiliate marketing agreement signed between Loop Insights and Impact Radius back on November 18th, 2020 .

Read More: https://agoracom.com/ir/LoopInsights/forums/discussion/topics/752607-loop-insights-selected-by-bdg-sports-to-provide-venue-management-platform-to-ncaa-big-west-conference-championships-at-mandalay-bay-in-las-vegas/messages/2296615#message

CLIENT FEATURE: Xphyto Therapeutics $XPHY.ca Providing Investor Access to Leading Edge Bioscience Opportunities $NGM.ca $SONA.ca $HBP.ca $MIR.ca $IPA.ca

Posted by AGORACOM at 12:37 PM on Thursday, January 7th, 2021

(CSE:XPHY / OTC:XPHYF / FSE:4XT)

  • Completed Successful SARS-CoV-2 RT-PCR Diagnostic Test Kit Validation
  • Secured Exclusive Psychedelic Drug Development Agreement
  • Appointed European Healthcare Executive to Board of Director
  • Engaged German Partner for Development of Psilocybin API Production
  • Announced Update on Contract Drug Delivery Program
  • Announced Update on Oral Thin Film Drug Delivery Program
  • Provided Update on Parkinson’s Transdermal Patch

Three Xphyto Divisions:

1. Vektor Pharma TF: World-class thin film drug delivery platforms for transdermal and oral dissolvable dosage forms

2. 3a-Diagnostics: Rapid, low-cost screening tests for pandemic and dental health applications

3. Xphyto Laboratories Inc.: Development of industrial production processes for emerging active pharmaceutical ingredients, including psychedelics and cannabinoid isolates

1. Vektor Pharma TF GmbH – Drug Delivery

100% owned XPhyto subsidiary

Global leader in design, testing and manufacture of therapeutic film drug delivery systems

  • Major pharma clients – past, present and future
  • Focused and nimble team – rapid turnaround on new opportunities

Versatile platform technology

  • Transdermal patches (TDS) – slow and steady release
  • Oral dissolvable film (ODF) sublingual strips – instant bioavailability

EU GMP facilities in Baden-Württemberg, Germany

Holder of numerous German narcotics import and manufacturing licences

XPhyto Drug Development Pipeline – Stage 1 & 2

  • Platform technology
  • Scalable product development pipeline
  • High-growth and new API opportunities
  • Neurological indications
  • Generic and hybrid-generic drug formulations

2. 3a-Diagnostics GmbH – Rapid Testing

XPhyto has an exclusive development, technology purchase and licence agreement

Specializing in the development, production, and marketing of low-cost point-of-care screening test systems:

  • COVID-19 rapid PCR Kit
  • COVID-19 disposable ultra-rapid test
  • Oral biosensors for the instant detection of bacterial and viral pathogens
  • Influenza A, H1N1 (swine flu), H5N1 (avian flu), Strep A, stomatitis, periimplantitis and periodontitis
  • Biosensor screening platform for high-throughput for identification of new biosensor targets for new biosensor products

Development partially funded by grants from the German Federal Ministry of Education and Research (BMBF)

Lead Products:

COVID-19 rapid PCR Kit

  • Diagnostic level accuracy, rapid results (<25 minutes), minimal lab equipment
  • European commercial approval and product launch planned for Q1 2021

Periimplantitis oral biosensor

  • For the early detection of infection associated with dental implants
  • Biosensor releases an extremely bitter compound when exposed to the causative pathogenic bacteria
  • European commercial approval and product launch planned for Q4 2021 

3. XPhyto Laboratories Inc. & Vektor Pharma TF GmbH – Psychedelics

100% owned XPhyto subsidiaries

Exclusive agreements with leading German and Canadian universities

Germany:

  • Development of psychedelic drug formulations – sublingual and transdermal
  • Development of biotechnology process for industrial scale production of psilocybin API
  • 12-month development program commenced Q3 2020

Canada:

  • Certified analytical testing for cannabis and psychedelics
  • Development programs for industrial scale and EU GMP production of mescaline, MDMA, DMT, and cannabinoid isolates
  • Novel psychedelic drug formulations

Clinical validation planned for Germany and Canada

Hub On AGORACOM / Corporate Profile

Datametrex $DM.ca $DTMXF Announces the Acquisition of Concierge Medical $PFM.ca $VQS.ca $SPOT.ca $ADK.ca

Posted by AGORACOM-JC at 7:49 AM on Thursday, January 7th, 2021
  • Announced today that it has entered into a binding Letter of Intent to acquire 100% of Concierge Medical Consultant Inc., an arm’s length private telehealth and medical concierge services company
  • Company believes that in the current pandemic environment that there is a likely increase in mental health issues in society attributed to periods of extended isolation and related the disruption of social interaction.
  • Accordingly, management of the Company feel that there is a significant need in the market place for provide personal health solutions and the Company recognizes telehealth and concierge medical service as a part of solution to this growing problem.

Toronto, Ontario–(January 7, 2021) –  Datametrex AI Limited (TSXV: DM) (FSE: D4G) (OTC Pink: DTMXF) (the “Company” or “Datametrex”) is pleased to announce today that it has entered into a binding Letter of Intent (the “LOI“) to acquire 100% of Concierge Medical Consultant Inc. (“Concierge“), an arm’s length private telehealth and medical concierge services company, incorporated under the laws of British Columbia (the “Transaction”).

Subject to the completion of satisfactory due diligence by both Datametrex and Concierge, under the terms and conditions of the LOI, Datametrex and Concierge will enter into a Definitive Agreement (the “Definitive Agreement“) on or about January 20, 2021.

The Company believes that in the current pandemic environment that there is a likely increase in mental health issues in society attributed to periods of extended isolation and related the disruption of social interaction. Accordingly, management of the Company feel that there is a significant need in the market place for provide personal health solutions and the Company recognizes telehealth and concierge medical service as a part of solution to this growing problem.

“We strongly believe that there is a growing need for remote health and wellness solutions as a result of the pandemic. The lockdowns and the isolation that Canadians have endured this past year have only increased the need for mental and physical health solutions. By providing Telehealth solutions we are able to keep people out of the already overwhelmed hospital infrastructure while at the same time providing Canadians with professional advice and care that they need and deserve.”, said Andrew Ryu, the Company’s Chairman.

Read More: https://agoracom.com/ir/DatametrexAI/forums/discussion/topics/752517-datametrex-announces-the-acquisition-of-concierge-medical/messages/2296435#message

Empower Clinics $CBDT.ca $EPWCF KAI Medical Laboratory Sells Out First 5,000 Units Of FDA EUA Approved Saliva #COVID-19 Test Kits. Issues Order For Next 25,000 KAI Saliva PCR Test Kits With Sales Value Of $5.5M. Discussions With Major Airlines Underway $WELL.ca $DOC.ca $DOCRF $VMD.ca

Posted by AGORACOM-JC at 7:44 AM on Thursday, January 7th, 2021

Kai Medical Laboratory, a state-of-the-art diagnostics laboratory in Dallas,TX was acquired by Empower Clinics on October 6, 2020 to further advance the Company’s COVID-19 national testing programs for enterprise clients, including movie and television studios, businesses and colleges

  • Announced the successful launch of our KAI Saliva PCR Test with our initial soft launch of 5,000 units sold out and the order of 25,000 additional units with a sales value of approximately $5,500,000.
  • Initial and overwhelming demand for KAI Saliva stemmed from our existing customers in film & television productions, the commercial sector, and concierge testing supported by Sun Valley Health in Arizona.
  • Given the early and significant success of KAI Saliva since its launch on December 15, 2020, Empower is extremely confident in the continued success of KAI Saliva with both existing and expanded commercial customers in this next run.

VANCOUVER, BC / January 7, 2021 / EMPOWER CLINICS INC. (CBDT:CSE)(8EC:Frankfurt)(EPWCF:OTCQB) (“Empower” or the “Company“) an integrated healthcare company serving patients through clinics, a telemedicine platform, and a leading medical diagnostics laboratory processing thousands of COVID-19 specimens and developing novel COVID-19 testing protocols for CE, FDA EUA and Health Canada approval, is pleased to announce the successful launch of our KAI Saliva PCR Test (“KAI Saliva”) with our initial soft launch of 5,000 units sold out and the order of 25,000 additional units with a sales value of approximately $5,500,000.

INITIAL DEMAND FOR FIRST RUN KAI SALIVA CAME FROM EXISTING COMMERCIAL CUSTOMERS, INCLUDING FILM & TELEVISION PRODUCTIONS. DIRECT TO CONSUMER CHANNEL LAUNCH IMMINENT

Initial and overwhelming demand for KAI Saliva stemmed from our existing customers in film & television productions, the commercial sector, and concierge testing supported by Sun Valley Health in Arizona. Given the early and significant success of KAI Saliva since its launch on December 15, 2020, Empower is extremely confident in the continued success of KAI Saliva with both existing and expanded commercial customers in this next run.

Read More: https://agoracom.com/ir/EmpowerClinics/forums/discussion/topics/752516-empower-clinics-kai-medical-laboratory-sells-out-first-5-000-units-of-fda-eua-approved-saliva-covid-19-test-kits/messages/2296434#message